ZTS — Zoetis Inc. stock price and chart

ZTS

Zoetis Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · MSCI ACWI 0.05% · S&P 500 0.05% · Russell 1000 0.04% · Russell 3000 0.04% · MSCI World 0.04% · US Stock Market 0.04%

$72.97+0.15%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

60.080.0100.0120.0140.0160.0180.0200.0220.0240.0050.0M$72.97

2026-09-11

Price$72.97

MA20$86.34

MA50$115.53

Vol29.0M

What would $1,000 invested in ZTS be worth today? →

ZTS returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $72.97
Change YTD: -41.10%
Next earnings: Nov 3, 2026
Market cap: 30.2B2016-09 25.7B2026-09 30.2B+17.1% over the window
Enterprise value: 37.8B
Shares outstanding: 413.2M2016-07 495M2026-06 413.2M-16.5% over the window
52W low: $71.00
52W high: $152.00
From 52W high: -51.99%
From 52W low: +2.77%
52W range: 2%
Beta: 0.74

Volume

Rel volume: 0.87×
30D volume: 6M
30D $ vol: 453.5M

Fundamentals

Sales (ttm): 9.5B2016-07 4.9B2026-06 9.5B+95.9% over the window
Sales/share: $23.032016-07 $9.812026-06 $23.03+134.7% over the window
EPS (ttm): $6.082016-07 $1.282026-06 $6.08+374.8% over the window
FCF (ttm): 2.3B2016-07 438M2026-06 2.3B+428.8% over the window
FCF/share: $5.602016-07 $0.882026-06 $5.60+533.5% over the window
Book value/share: $7.622016-07 $2.742026-06 $7.62+177.9% over the window
Net margin: 27.49%2016-07 13.2%2026-06 27.5%+109.0% over the window
ROE: 83.10%2016-07 47.1%2026-06 83.1%+76.5% over the window
ROA: 17.35%2016-07 8.5%2026-06 17.4%+104.1% over the window
Debt / equity: 2.87×2016-07 3.292026-06 2.87-12.6% over the window
Current ratio: 3.082016-07 3.202026-06 3.08-3.7% over the window

Growth (CAGR, ttm) · 10Y

Sales: +1.49%2025-06-30 → 2026-06-309.4B → 9.5B (+1.5% total)+5.00%2023-06-30 → 2026-06-308.2B → 9.5B (+15.8% total)+5.13%2021-06-30 → 2026-06-307.4B → 9.5B (+28.4% total)+6.96%2016-07-03 → 2026-06-304.9B → 9.5B (+95.9% total)
Net income: +0.97%2025-06-30 → 2026-06-302.6B → 2.6B (+1.0% total)+5.73%2023-06-30 → 2026-06-302.2B → 2.6B (+18.2% total)+6.51%2021-06-30 → 2026-06-301.9B → 2.6B (+37.0% total)+15.15%2016-07-03 → 2026-06-30639M → 2.6B (+309.4% total)
FCF: +2.07%2025-06-30 → 2026-06-302.3B → 2.3B (+2.1% total)+21.69%2023-06-30 → 2026-06-301.3B → 2.3B (+80.2% total)+6.36%2021-06-30 → 2026-06-301.7B → 2.3B (+36.1% total)+18.14%2016-07-03 → 2026-06-30438M → 2.3B (+428.8% total)
Shares: -6.76%2025-06-30 → 2026-06-30443.2M → 413.2M (-6.8% total)-3.53%2023-06-30 → 2026-06-30460.3M → 413.2M (-10.2% total)-2.71%2021-06-30 → 2026-06-30473.9M → 413.2M (-12.8% total)-1.79%2016-07-03 → 2026-06-30495M → 413.2M (-16.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +5.44%2025-06-30 → 2026-06-30$5.76 → $6.08 (+5.4% total)+8.55%2023-06-30 → 2026-06-30$4.75 → $6.08 (+27.9% total)+8.76%2021-06-30 → 2026-06-30$3.99 → $6.08 (+52.2% total)+16.87%2016-07-03 → 2026-06-30$1.28 → $6.08 (+374.8% total)
Sales/share: +8.86%2025-06-30 → 2026-06-30$21.16 → $23.03 (+8.9% total)+8.84%2023-06-30 → 2026-06-30$17.86 → $23.03 (+28.9% total)+8.05%2021-06-30 → 2026-06-30$15.64 → $23.03 (+47.3% total)+8.91%2016-07-03 → 2026-06-30$9.81 → $23.03 (+134.7% total)
FCF/share: +9.48%2025-06-30 → 2026-06-30$5.12 → $5.60 (+9.5% total)+26.15%2023-06-30 → 2026-06-30$2.79 → $5.60 (+100.8% total)+9.31%2021-06-30 → 2026-06-30$3.59 → $5.60 (+56.1% total)+20.30%2016-07-03 → 2026-06-30$0.88 → $5.60 (+533.5% total)
Book value/share: -32.18%2025-06-30 → 2026-06-30$11.23 → $7.62 (-32.2% total)-8.81%2023-06-30 → 2026-06-30$10.05 → $7.62 (-24.2% total)-3.66%2021-06-30 → 2026-06-30$9.18 → $7.62 (-17.0% total)+10.77%2016-07-03 → 2026-06-30$2.74 → $7.62 (+177.9% total)
Dividend/share: +13.79%2025-06-30 → 2026-06-30$1.89 → $2.15 (+13.8% total)+15.01%2023-06-30 → 2026-06-30$1.41 → $2.15 (+52.1% total)+18.96%2021-06-30 → 2026-06-30$0.90 → $2.15 (+138.2% total)+19.68%2016-07-03 → 2026-06-30$0.36 → $2.15 (+501.7% total)
Price: -51.57%2025-09-11 → 2026-09-11$150.61 → $72.97 (-51.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-26.80%2023-09-11 → 2026-09-11$186.07 → $72.97 (-60.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-18.82%2021-09-10 → 2026-09-11$207.00 → $72.97 (-64.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+3.77%2016-09-09 → 2026-09-11$50.39 → $72.97 (+44.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -50.64%2025-09-11 → 2026-09-11$147.77 → $72.97 (-50.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-25.79%2023-09-11 → 2026-09-11$178.60 → $72.97 (-59.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-17.90%2021-09-10 → 2026-09-11$195.69 → $72.97 (-62.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.68%2016-09-09 → 2026-09-11$46.16 → $72.97 (+58.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 12.0×2016-09 40.292026-09 11.53-71.4% over the window
Fwd P/E: 11.6×
P/S (ttm)Market cap ÷ TTM revenue.: 3.2×2016-09 5.302026-09 3.17-40.2% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 9.6×2016-09 18.972026-09 9.58-49.5% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 13.0×2016-09 58.782026-09 13.02-77.8% over the window
EV/EBITDA (fy): 9.5×
EV/Sales (ttm): 4.0×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 7.68%2016-07 1.7%2026-06 7.8%+358.7% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 2.95%
Dividend/share (fwd): $2.15
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 413.2M ÷ 443.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 6.76%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (6.76%) + dividends paid over that year ($889M) ÷ market_cap_at(2025-06-30) ($69.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 8.05%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($3.6B) ÷ today's market cap ($30.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 12.09%2016-07 1.0%2026-06 12.3%+1144.6% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $3.6B + TTM dividends $889M) ÷ today's market cap ($30.2B). Same caveat as the cash buyback yield.: 15.03%2016-07 1.7%2026-06 15.3%+812.4% over the window

Vs own 10Y history

P/E: 0th
P/S: 0th
P/B: 0th
P/FCF: 0th

Bar = where today’s multiple sits in ZTS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+0.15%

-4.35%

-0.78%

-9.73%

YTD

-41.10%

-50.23%

-63.11%

Financial statements

Open full ZTS financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Zoetis Inc. (ZTS) trades at $72.97 with a live price and an interactive chart covering 13+ years of daily price history, plus key valuation metrics. ChartRow also publishes ZTS’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ZTS financial statements →

ZTS — Zoetis Inc. price, chart and key statistics